VitrOmics is focusing on the development of, among other things, new diagnostic products based on the PamChip® technology platform. The application field is tailor-made therapy (personalized/ precision medicine). The PamChip platform was developed by VirtOmics subsidiary PamGene (www.pamgene.com) and is already used worldwide for a variety of academic and bio-pharmaceutical research applications. There is also an important link with other companies involved in personalized medicine such as Pepscan (www.pepscan.com), personalized medicines peptides and Lead Pharma (www.leadpharma.com).
VitrOmics sees an important role for personlized medicine in improving therapy choices for the individual patient and has initiated a number of prospective clinical studies together with care providers and health insurers.